Kendra Pierre-Louis: For Scientific American’s Science Rapidly, I’m Kendra Pierre-Louis, in for Rachel Feltman.
Over the previous few years GLP-1 medication have gone from comparatively obscure diabetes medicines to family names for weight reduction. The pattern actually took off in 2021, when the FDA accredited semaglutide for weight reduction, bought below the model names Ozempic and Wegovy. Should you’re not taking one, somebody in your life doubtless is. That features celebrities comparable to Meghan Trainor and Serena Williams, who say they’ve used GLP-1 injectables.
With the rising reputation of those medicines, drugmakers are busy creating newer and stronger formulations. This week the primary GLP-1 weight-loss capsule grew to become obtainable within the U.S.: an oral model of Wegovy. And rising analysis suggests GLP-1s might need makes use of past diabetes and weight reduction, too.
On supporting science journalism
Should you’re having fun with this text, contemplate supporting our award-winning journalism by subscribing. By buying a subscription you’re serving to to make sure the way forward for impactful tales concerning the discoveries and concepts shaping our world at the moment.
However how do these medication truly work? And do they actually stand as much as the hype? To get a greater understanding of the GLP-1 panorama, we reached out to Bethany Brookshire, a contract journalist who has extensively coated these medicines.
Thanks a lot for becoming a member of us at the moment.
Bethany Brookshire: Thanks for having me.
Pierre-Louis: I do know that you simply’ve carried out quite a lot of work on GLP-1s, and so are you able to inform us, at a primary degree: What’s a GLP-1, after which what’s a GLP-1 drug?
Brookshire: Yeah, GLP-1 is glucagon-like peptide 1. It’s produced within the gut in response to meals consumption, so, like, whenever you eat, it’s produced. It often, truly—it circulates within the blood, however it’s minimize off fairly fast.
Pierre-Louis: Mm-hmm.
Brookshire: You’ve an enzyme that often breaks it down in a short time.
And what this does is it will increase your insulin secretion; it inhibits one other hormone known as glucagon. So it slows gastric emptying, it makes you are feeling full, it will increase satiety, and so it adjustments type of the best way that you simply feed.
So you’ve two completely different sorts of feeding: you’ve homeostatic feeding and [hedonic] feeding. And homeostatic feeding is simply, like, you’re ravenous …
Pierre-Louis: Mm-hmm.
Brookshire: And also you’re gonna eat, and, like, this factor in entrance of you isn’t nice, however you’re hungry, and there you go. That’s homeostatic feeding, and also you’ll eat sufficient of it, however you’re not gonna go loopy.
Whereas [hedonic] feeding is like, “I actually take pleasure in—we’re recording throughout the holidays, and I actually benefit from the style of cheese …”
Pierre-Louis: [Laughs.]
Brookshire: “And I wish to be stuffed with quite a lot of cheese,” and also you eat quite a lot of cheese, and also you eat cheese even whenever you shouldn’t eat cheese as a result of it’s nice. That’s [hedonic] feeding. [Laughs.] Otherwise you do it for emotional causes—there’s numerous causes …
Pierre-Louis: Proper.
Brookshire: Folks may overeat. And GLP-1, the hormone, prevents that type of factor. It promotes satiety and says, “Okay, you’re minimize off. You had sufficient.”
Pierre-Louis: And to be clear, that is, like, naturally produced—like, our physique naturally produces …
Brookshire: Sure.
Pierre-Louis: This hormone.
Brookshire: Sure, so your physique naturally produces GLP-1, and GLP-1 prompts GLP-1 receptors, which is the way it produces its results. So these GLP-1 receptors are all around the physique. They’re all around the mind. They’re always doing issues. And so you’ve these receptors, and the place you’ve receptors you possibly can create medication to activate these receptors.
And so the medication which can be mimicking GLP-1 are known as GLP-1 receptor agonists. And once we say “agonist” in pharmacology what we imply is that it activates the receptor, so it’s mimicking your regular GLP-1, proper? If it had been blocking it, we’d name it an antagonist. However these are all agonists, so they’re stimulating that receptor. They’re saying, “Go, go, go.”
And so GLP-1 receptor agonists is what they’re known as within the literature, however in fact, in public discourse we’ve simply began calling them GLP-1s. And these are the medication like semaglutide, liraglutide, exenatide, tirzepatide—the “-atides” [Laughs] as a result of pharma loves to call issues. These are activators of those receptors. They’re simply appearing like GLP-1, a lot tougher [Laughs] and for much longer than your endogenous GLP-1 would.
Pierre-Louis: So usually, the GLP-1 that our physique produces, it will get produced after we eat one thing, it hangs round for a comparatively brief time frame, and it goes away …
Brookshire: Mm-hmm, sure.
Pierre-Louis: However once we take these GLP-1 agonists, these medication, it type of lingers in our system for lots longer, type of creating a much bigger sense of satiety than we’d naturally.
Brookshire: Sure, they linger quite a bit longer. I imply, lord is aware of with the injectables you are taking them as soon as every week—they linger a extremely very long time.
Pierre-Louis: Mm-hmm.
Brookshire: And so they’re additionally at a lot larger doses, so that they’re hammering that receptor a lot tougher than the pure GLP-1 that you simply may produce.
Pierre-Louis: And initially—these medication have been round for some time. However initially, they had been principally for diabetes, is my understanding.
Brookshire: Sure, the primary GLP-1 receptor agonists had been accredited for diabetes, and that’s partially as a result of they improve insulin secretion, which is essential if in case you have sort 2 diabetes and you’re much less delicate to insulin otherwise you don’t produce sufficient insulin; it inhibits glucagon, so it slows your gastric emptying. The results of GLP-1 receptor agonists on blood sugar ranges and on insulin are unparalleled. They’re unimaginable medication for diabetes, and so they’ve been an actual recreation changer in sort 2 diabetes remedy. They’re actually nice for that.
Pierre-Louis: After which they’ve type of risen to this public consciousness as a result of as they had been used for sort 2 diabetes we grew to become conscious of type of, like, a aspect impact, which is it helps some individuals shed pounds.
Brookshire: Sure, it helps a lot of individuals shed pounds. And yeah, the doses which can be used for sort 2 diabetes administration specifically …
Pierre-Louis: Mm-hmm.
Brookshire: Don’t trigger as a lot weight reduction; they’re decrease doses. So individuals—after they began noticing that some individuals had been dropping pounds on these medication the pharmaceutical corporations had been like, “Hmm, sniff, sniff, I odor cash,” and began type of working with larger doses of the medication to provide extra weight reduction, and so that you see a lot larger doses. For instance, Ozempic is for diabetes, and Wegovy is for weight reduction. They’re each the identical drug—they’re each semaglutide—however semaglutide in Wegovy is far larger. So there’s larger doses which can be required to provide the burden loss.
Pierre-Louis: And due to that weight-loss profit, if you’ll, we now have far more individuals on these medication. Like, how many individuals nationwide are on a GLP-1 at any given time?
Brookshire: You understand, it’s laborious to seek out the numbers. I see some numbers saying that one in eight People …
Pierre-Louis: Mm-hmm.
Brookshire: Have taken GLP-1s. And be mindful, in fact, not all people is on them for a protracted time frame. There are lots of people who give up them …
Pierre-Louis: Mm-hmm.
Brookshire: For varied causes: both they’ve misplaced the burden they need; perhaps it’s not working in addition to they need; the negative effects are insupportable, which they actually may be. However I’ve seen one in eight People have been on them. We all know, in 2024, [about] 1 / 4 of individuals with sort 2 diabetes had been on GLP-1s, so—clearly, individuals taking them for sort 2 diabetes are completely different from individuals simply taking them for weight reduction.
And I additionally was seeing numbers saying, “Nicely, you realize, one out of each 5 children—“is now technically ‘overweight’”—I put that in air quotes—and so due to this fact, they may very well be eligible to take these medication.
Pierre-Louis: That’s lots of people.
Brookshire: It’s quite a bit of individuals.
Pierre-Louis: And I wanna discuss slightly bit extra about what which means when it comes to newer medication popping out and successes and negative effects. However earlier than we go down that path, one of many different issues that has come out is that GLP-1s do appear to have different knock-on results past weight reduction and past diabetes, and so are you able to discuss slightly bit about a few of the potential of GLP-1s for different well being situations?
Brookshire: Proper now GLP-1s are very a lot of their “What can’t it do?” section. And the factor is you then discover out what it might probably’t do, and there are various issues these medication can’t do.
We do know that they may help quite a bit with cardiovascular issues. So individuals who have, you realize, type of long-term cardiovascular difficulties, these medication can actually assist with that. They actually assist with metabolic dysfunction; as we’ve stated, like, for insulin they’re a recreation changer. We’ve seen some fascinating results on issues like irritation.
Pierre-Louis: Mm-hmm.
Brookshire: So individuals who undergo a type of long-term power irritation can have some constructive results.
As we talked about it’s energetic within the mind, and it controls—it helps type of nudge completely different type of chemical messengers within the mind …
Pierre-Louis: Mm-hmm.
Brookshire: Together with serotonin and together with dopamine. And so there’s some actually essential proof that it may actually assist people who find themselves scuffling with issues like alcoholism as a result of it makes medication and it makes alcohol a lot much less interesting, which is—I imply, that’s nice; that is an extremely troublesome dysfunction.
It has additionally been checked out for issues like Alzheimer’s, which it had method much less success. There was, like, a small impact, and it doesn’t seem to have labored out.
It does seem to assist issues like, probably, joint ache …
Pierre-Louis: Mm-hmm.
Brookshire: And naturally, that may very well be as a result of it has some constructive results on irritation. It may be as a result of for people who find themselves in very massive our bodies, you realize, joints may be actually troublesome, and so taking off a few of that weight may help with joints.
So sure, there are quite a lot of completely different type of knock-on results right here. There’s some actually fascinating and compelling analysis displaying it might assist a few of the results of polycystic ovarian syndrome …
Pierre-Louis: Mm-hmm.
Brookshire: Which is a extremely nasty and much more frequent dysfunction than individuals notice.
Pierre-Louis: Yeah.
Brookshire: And it may probably, in some instances, assist with fertility, both with serving to individuals attain weight cutoffs in order that they are often accredited for fertility remedy or in that they might assist type of restore or enhance fertility in individuals for whom—if, if they’re in bigger our bodies and have metabolic dysfunction, bettering metabolic perform can generally assist with fertility.
So there, there’s a bunch of potential impacts which can be actually constructive and will actually, actually assist some individuals.
Pierre-Louis: That’s actually promising and fascinating, and since we’re type of on this heady second of individuals being actually awed by these medication, it looks like an increasing number of of them are popping out. I do know that for the primary time the FDA accredited an oral GLP-1 particularly for weight reduction. Are you able to discuss a bit about this new capsule and likewise type of what we’re seeing in type of the GLP-1 pipeline?
Brookshire: There’s a lot. So semaglutide—that’s your Ozempic; that’s your Wegovy. That’s from Novo Nordisk. It was accredited simply earlier than Christmas, December 22.
There have been some challenges with creating these medication as a capsule. They’re principally injectable proper now, and other people don’t like taking needles. [Laughs.] No person needs it. So you realize that in the event that they’re releasing one thing as a needle, it’s as a result of it’s actually laborious …
Pierre-Louis: Yeah.
Brookshire: To get it to do anything.
And on this case it’s a bioavailability situation. So principally, this can be a gastrointestinal hormone that GLP-1 receptor agonists are mimicking, proper?
Pierre-Louis: Mm-hmm.
Brookshire: Issues within the gastrointestinal tract get damaged down actually, actually quick, and so …
Pierre-Louis: Yep.
Brookshire: Once you’re taking one thing orally, as a capsule, like, little or no of that’s gonna make it into your bloodstream, and in order that’s been an actual problem.
So for instance, the efficient dose of semaglutide for weight reduction is 2.4 milligrams injected.
Pierre-Louis: Mm-hmm.
Brookshire: As a capsule it’s 25 milligrams, so that they actually needed to go up. And one of many main negative effects is gastrointestinal upset: nausea, constipation, actually nasty vomiting …
Pierre-Louis: Mm-hmm.
Brookshire: It’s very upsetting. Heartburn. There’s a—sulfurous burps is a giant one …
Pierre-Louis: That could be a very descriptive time period.
Brookshire: Sorry. [Laughs.]
Pierre-Louis: [Laughs.]
Brookshire: It’s true! [Laughs.] Anyway, so the negative effects may be very uncomfortable. After which should you’re taking a capsule, you’re taking the factor inflicting these negative effects and you’re dropping it proper into the abdomen. [Laughs.]
Pierre-Louis: Yeah.
Brookshire: The negative effects have been actually laborious to fight.
Pierre-Louis: Mm-hmm.
Brookshire: You’re not eliminating these anytime quickly, I can inform you.
However Novo Nordisk has lastly carried out it, and so they’ve proven the capsule has [a] 16.6 imply weight reduction share over 64 weeks, in order that’s about even with the injectable. However they’re not the one ones as a result of Eli Lilly won’t ever be outdone by Novo Nordisk. It is a pharma arms race, like, of which the world has by no means seen. And they’re making an attempt an oral drug known as orforglipron.
Pierre-Louis: [Laughs.] That could be a mouthful.
Brookshire: [Laughs.] It’s a GLP-1 receptor agonist. It’s an oral drug. It’s alleged to be cheaper. The gastrointestinal negative effects, once more, appear to be fairly unhealthy. And also you even have to recollect: there may be one other drug known as Rybelsus. Rybelsus already exists. It’s already accredited. It’s an oral GLP-1.
Pierre-Louis: Mm-hmm.
Brookshire: It’s accredited for sort 2 diabetes.
The Rybelsus and the oral semaglutide each of them have actual restrictions round how they should be taken. So you must take them very first thing within the morning …
Pierre-Louis: Mm-hmm.
Brookshire: You may take them with not more than 4 ounces of water, after which you could eat or drink nothing for half-hour. It’s gonna be a burden, however I additionally—if I had been a betting particular person, I imply, a capsule’s gonna be method extra common …
Pierre-Louis: Yeah.
Brookshire: Than having to take an injectable that must be saved within the fridge and, you realize, is tough to get.
So yeah, these are all on the best way. There are additionally new injectables …
Pierre-Louis: Mm-hmm.
Brookshire: Which are on the best way as nicely.
Pierre-Louis: And people are?
Brookshire: So there are two large ones that I’m seeing popping out. The largest one which I’m already seeing individuals take—should you hunt it down on, like, social media, TikTok specifically, you could find individuals already getting this drug from compounding pharmacies. It’s, I consider, pronounced “RET-ah-TRU-tide.”
Pierre-Louis: Mm-hmm.
Brookshire: I wanna name it “re-TAH-tru-TIDE.” And so individuals name it reta, for apparent causes. [Laughs.] And reta, large section 2 outcomes got here out for that in 2023. It’s an Eli Lilly drug. I’m seeing 24 % weight reduction and even larger, as much as a 3rd of physique weight …
Pierre-Louis: Oh, wow.
Brookshire: In 48 weeks.
Pierre-Louis: That’s an unimaginable quantity of weight.
Brookshire: It’s quite a bit.
After which there’s one other one that’s …
Pierre-Louis: Mm-hmm.
Brookshire: Novo Nordisk. Novo Nordisk is basically on this drug known as CagriSema. And so CagriSema is definitely not one drug that does a number of issues; it’s two medication that every do one factor. And on this case it’s a mixture drug, and if persons are absolutely adherent, [roughly] 40 % of sufferers misplaced 1 / 4 [or more] of their physique weight. And once more, they filed for FDA approval for CagriSema on December 18.
So, I imply, pharmaceutical corporations know the place the cash is.
Pierre-Louis: You raised one thing fascinating, I feel, whenever you had been speaking about how if you realize a compounding pharmacist, you may get reta—or some persons are accessing it. Can we discuss slightly bit about this, like, grey market of GLP-1s? Which is wild to me since you are speaking about injecting one thing into your physique that will not have the oversight that you simply’re anticipating.
Brookshire: Yeah, so compounding pharmacies play an fascinating function within the U.S. drug system. Compounding pharmacies could be a actual lifeline when individuals can’t get particular medication …
Pierre-Louis: Mm-hmm.
Brookshire: That they desperately want. So for instance, I do know for lots of people with main pores and skin situations—and that features me; I depend on compounding pharmacies to compound the topical steroids that principally maintain my pores and skin collectively. [Laughs.] So, you realize, compounding pharmacies are actually essential for that type of factor.
When the GLP-1s first type of actually got here to public consideration, 2022, 2023, for weight reduction there was an actual scarcity …
Pierre-Louis: Mm-hmm.
Brookshire: Of the medication. Novo Nordisk specifically simply couldn’t sustain with demand. Like, the whole nation of Denmark was producing these medication. [Laughs.] And so the federal authorities stated, “Okay, compounding pharmacies could make these medication …”
Pierre-Louis: Yep.
Brookshire: “For this time period,” and you are able to do it for cheaper as a result of they’re usually cheaper.
And so individuals began gaining access to them through these compounding pharmacies. And I feel that additionally has led lots of people to type of belief these pharmacies, proper?
Pierre-Louis: Mm-hmm.
Brookshire: A lot of them have been injecting these medication from these pharmacies for years now.
Pierre-Louis: Yep.
Brookshire: Proper? Why wouldn’t they belief it? And to be clear compounding pharmacies aren’t inherently untrustworthy outfits. However they don’t seem to be topic to the identical scrutiny. They’re type of making small-batch variations …
Pierre-Louis: Mm-hmm.
Brookshire: Of those medication. And naturally, they’re not essentially dosed or formulated. So whenever you get the key medication, the key GLP-1 agonists, from the businesses you get them in these little dosing pens. They’re already, like, measured out and all the pieces. Once you get them from a compounding pharmacy you get a vial and a needle and a few hope. And so individuals should measure it out themselves, and this may be simply wonderful.
Pierre-Louis: Mm-hmm.
Brookshire: It might additionally introduce human error, and it might probably additionally permit individuals to misuse them.
Individuals who have histories of consuming problems …
Pierre-Louis: Mm-hmm.
Brookshire: Discover these medication terribly compelling. For individuals with anorexia, individuals with bulimia, medication like these—you realize, there may be nothing that you really want greater than to fully kill your urge for food. [Laughs.] And they also’re actually compelling, and I’ve seen case studies of people that have been hospitalized as a result of they’ve, you realize, been taking greater than they need to. They’ve been taking it with out a prescription. They’ve been acquiring it quasi-legally at finest.
Pierre-Louis: Proper.
Brookshire: In order that does occur. There are additionally just a few total type of downsides …
Pierre-Louis: Mm-hmm.
Brookshire: To those medication, proper? Like, we’ve talked concerning the negative effects. I discussed that GLP-1 receptors are all around the mind. One of many locations they’re within the mind is on this space of the mind known as the realm postrema, which feels like some type of weird combined martial artwork however is definitely a mind space accountable for vomiting. [Laughs.]
Pierre-Louis: Oh. [Laughs.]
Brookshire: Yeah. [Laughs.] So, you realize, so long as you’ve these medication hitting these receptors you’re gonna have these gastrointestinal negative effects. It’s gonna be unhealthy.
We all know that overactivation of GLP-1 receptors …
Pierre-Louis: Mm-hmm.
Brookshire: So actually excessive doses …
Pierre-Louis: Mm-hmm.
Brookshire: May also have psychiatric negative effects. It might trigger despair. It might trigger apathy, nervousness. And this isn’t tremendous stunning when you concentrate on it. You understand, quite a lot of the signs of despair and apathy specifically is a sense known as anhedonia …
Pierre-Louis: Yep.
Brookshire: Which is principally unable to have the benefit of issues, and GLP-1s make meals lose pleasure. They make meals gasoline, and many individuals suppose they need this. However perhaps you don’t [Laughs], proper? That may be actually troublesome.
We talked about anorexia and bulimia, however there’s additionally—persons are eager about utilizing GLP-1s for binge-eating dysfunction …
Pierre-Louis: Mm-hmm.
Brookshire: Which is the most typical of the consuming problems. And whereas it might probably actually assist with individuals bingeing it doesn’t essentially deal with the underlying dysfunction, so, like, it doesn’t deal with why somebody is bingeing, proper?
Pierre-Louis: Proper.
Brookshire: And in order that’s one thing that individuals who deal with consuming problems are involved about with these medication.
Extra virtually talking, a few of the higher-dose medication, so tirzepatide …
Pierre-Louis: Mm-hmm.
Brookshire: Tirzepatide can lower the efficacy of oral contraception as a result of it causes the medication to remain in your abdomen longer ’trigger it makes all the pieces keep in your abdomen longer—it delays gastric emptying.
You might have heard the time period “Ozempic infants.” Ozempic infants aren’t truly an actual factor. It’s extra that very fast weight reduction may cause recalibration of menstrual biking in some individuals. And so you will note this with fast weight reduction from GLP-1s, although you’ll additionally see it with fast weight reduction from bariatric surgical procedure; individuals have pregnancies after bariatric surgical procedure for related causes.
One other draw back is the medication are tremendous costly …
Pierre-Louis: Yeah.
Brookshire: And we all know this. Folks don’t essentially wanna be on them without end …
Pierre-Louis: Mm-hmm.
Brookshire: Proper? And this can be a chemical weight loss plan, principally. It’s a chemical weight loss plan that you’re placing your physique and your mind on. And when your physique and mind is just not on that weight loss plan individuals regain the burden. They’re going to regain it; they might achieve much more.
We additionally know that the very excessive, fast weight reduction may cause very troublesome results on the liver and the gallbladder specifically. And this isn’t particular, once more, to the GLP-1s—it’s the burden loss. And so that you get individuals who should get their gallbladders out quite a bit or undergo fairly unhealthy gallstones, liver issues, issues like that. All of these are type of the negative effects of the fast weight reduction.
And, you realize, weight reduction itself, it’s one thing that is essential to lots of people as a result of our society could be very merciless to individuals in bigger our bodies for a lot of, many causes. And so it’s totally affordable that you simply’d need all the advantages of those medication, nevertheless it’s not a silver bullet, proper, ’trigger nothing is.
Pierre-Louis: That’s our present. Don’t neglect to tune in on Monday, once we’ll offer you a rundown on what’s been occurring in science information.
Science Rapidly is produced by me, Kendra Pierre-Louis, together with Fonda Mwangi, Sushmita Pathak and Jeff DelViscio. This episode was edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check our present. Our theme music was composed by Dominic Smith. Subscribe to Scientific American for extra up-to-date and in-depth science information.
For Scientific American, that is Kendra Pierre-Louis. See you subsequent time!
